PA
KODK icon

PharVision Advisers’s Kodak KODK Stock Holding History

PharVision Advisers’s Portfolio KODK Stock Details KODK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$106K Sell
11,743
-21,268
-64% -$162K 1.08% 44
2025
Q4 		$279K Buy
33,011
+20,259
+159% +$151K 0.14% 313
2025
Q3 		$81.7K Buy
+12,752
New +$80.3K 0.05% 636

Other funds holding KODK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

PharVision Advisers's KODK Position: Q1 2026 in Review

PharVision Advisers reduced its Kodak (KODK) stake by 64% in Q1 2026, selling an estimated $162K and leaving 11,743 shares worth $106K. The position accounts for 1.08% of the portfolio, ranked #44.

PharVision Advisers first reported a position in KODK in Q3 2025 and has held it in 3 quarters since. The position peaked at $279K in Q4 2025. 163 funds tracked by Wall St. Rank hold KODK as of Q1 2026.

  • PharVision Advisers held 11,743 shares of Kodak worth $106K as of Q1 2026.
  • PharVision Advisers sold 21,268 Kodak shares in Q1 2026, an estimated $162K.
  • Kodak made up 1.08% of PharVision Advisers's portfolio in Q1 2026, its #44 holding.
  • PharVision Advisers first reported a position in Kodak in Q3 2025 and has held it in 3 quarters since.
  • PharVision Advisers's Kodak position peaked at $279K in Q4 2025.
  • 163 funds tracked by Wall St. Rank held Kodak as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.